L. Valeur-diagnostique-du and C. , exprimé comme une variable continue et non plus sous forme binaire) peut être présentée sous la forme d'une courbe ROC (Receiver Operating Characteristic))

T. Murray, The history of multiple sclerosis: the changing frame of the disease over the centuries, Journal of the Neurological Sciences, vol.277, issue.1, pp.3-8, 2009.
DOI : 10.1016/S0022-510X(09)70003-6

R. Bove, B. Healy, A. Augustine, A. Musallam, T. Gholipour et al., Effect of gender on late-onset multiple sclerosis, Multiple Sclerosis Journal, vol.13, issue.10, pp.1472-1481, 2012.
DOI : 10.1038/nature10251

A. Ghezzi, V. Deplano, J. Faroni, M. Grasso, M. Liguori et al., Multiple sclerosis in childhood: clinical features of 149 cases, Multiple Sclerosis, vol.3, issue.1, pp.43-49, 1997.
DOI : 10.1177/135245859700300105

M. Cossburn, G. Ingram, C. Hirst, Y. Ben-shlomo, T. Pickersgill et al., Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis, Multiple Sclerosis Journal, vol.124, issue.1, pp.45-54, 2012.
DOI : 10.1136/jnnp.2007.124123

T. Kalincik, V. Vivek, V. Jokubaitis, J. Lechner-scott, M. Trojano et al., Sex as a determinant of relapse incidence and progressive course of multiple sclerosis, Brain, vol.136, issue.12, pp.3609-3626, 2013.
DOI : 10.1093/brain/awt281

A. Fromont, C. Binquet, E. Sauleau, I. Fournel, A. Bellisario et al., Geographic variations of multiple sclerosis in France, Brain, vol.133, issue.7, pp.1889-99, 2010.
DOI : 10.1093/brain/awq134

A. Fromont, C. Binquet, E. Sauleau, I. Fournel, R. Despalins et al., National estimate of multiple sclerosis incidence in France (2001???2007), Multiple Sclerosis Journal, vol.1210, issue.8, pp.1108-1123, 2001.
DOI : 10.3917/pope.701.0139

J. Ouallet and B. Brochet, Aspects cliniques, physiopathologiques, et th??rapeutiques de la scl??rose en plaques, EMC - Neurologie, vol.1, issue.4, pp.415-57, 2004.
DOI : 10.1016/j.emcn.2004.05.002

S. Vukusic, V. Bockstael, V. Gosselin, S. Confavreux, and C. , Regional variations in the prevalence of multiple sclerosis in French farmers, Journal of Neurology, Neurosurgery & Psychiatry, vol.78, issue.7, pp.707-716, 2007.
DOI : 10.1136/jnnp.2006.101196

C. Poser, D. Paty, L. Scheinberg, W. Mcdonald, F. Davis et al., New diagnostic criteria for multiple sclerosis: Guidelines for research protocols, Annals of Neurology, vol.122, issue.3, pp.227-258, 1983.
DOI : 10.1002/ana.410130302

W. Mcdonald, A. Compston, G. Edan, D. Goodkin, H. Hartung et al., Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis, Annals of Neurology, vol.70, issue.1
DOI : 10.1002/ana.1032

F. Barkhof, M. Filippi, D. Miller, P. Scheltens, A. Campi et al., Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis, Brain, vol.120, issue.11, pp.2059-69, 1997.
DOI : 10.1093/brain/120.11.2059

C. Polman, S. Reingold, G. Edan, M. Filippi, H. Hartung et al., Diagnostic criteria for multiple sclerosis: 2005 revisions to the ???McDonald Criteria???, Annals of Neurology, vol.6, issue.6, pp.840-846, 2005.
DOI : 10.1002/ana.20703

C. Polman, S. Reingold, B. Banwell, M. Clanet, J. Cohen et al., Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Annals of Neurology, vol.64, issue.suppl 2, pp.292-302, 2011.
DOI : 10.1002/ana.22366

A. Ruet, G. Arrambide, B. Brochet, C. Auger, E. Simon et al., Early predictors of multiple sclerosis after a typical clinically isolated syndrome, Multiple Sclerosis Journal, vol.21, issue.13, 2014.
DOI : 10.1212/01.wnl.0000280576.73609.c6

D. Chard, C. Dalton, J. Swanton, L. Fisniku, K. Miszkiel et al., MRI only conversion to multiple sclerosis following a clinically isolated syndrome, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.2, pp.176-185, 2011.
DOI : 10.1136/jnnp.2010.208660

C. Dalton, B. Bodini, R. Samson, M. Battaglini, L. Fisniku et al., Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis, Multiple Sclerosis Journal, vol.67, issue.3, pp.322-330, 2012.
DOI : 10.1177/197140099200500413

F. Lublin and S. Reingold, Defining the clinical course of multiple sclerosis: Results of an international survey, Neurology, vol.46, issue.4, pp.907-918, 1996.
DOI : 10.1212/WNL.46.4.907

A. Compston and A. Coles, Multiple sclerosis, The Lancet, vol.359, issue.9313, pp.1221-1252, 2002.
DOI : 10.1016/S0140-6736(02)08220-X

URL : https://hal.archives-ouvertes.fr/hal-00996686

A. Thompson, C. Polman, D. Miller, W. Mcdonald, B. Brochet et al., Primary progressive multiple sclerosis, Brain, vol.120, issue.6, pp.1085-96, 1997.
DOI : 10.1093/brain/120.6.1085

S. Vukusic and C. Confavreux, The Natural History of Multiple Sclerosis, Presse Med. mars, vol.39, issue.3, pp.359-62, 2010.
DOI : 10.1201/9780824741846.ch17

C. Confavreux and S. Vukusic, Age at disability milestones in multiple sclerosis, Brain, vol.129, issue.3, pp.595-605, 2006.
DOI : 10.1093/brain/awh714

C. Confavreux, S. Vukusic, and P. Adeleine, Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process, Brain, vol.126, issue.4, pp.770-82, 2003.
DOI : 10.1093/brain/awg081

URL : https://hal.archives-ouvertes.fr/hal-00427394

E. Leray, J. Yaouanq, L. Page, E. Coustans, M. Laplaud et al., Evidence for a two-stage disability progression in multiple sclerosis, Brain, vol.133, issue.7, pp.1900-1913, 2010.
DOI : 10.1093/brain/awq076

H. Brønnum-hansen, N. Koch-henriksen, and E. Stenager, Trends in survival and cause of death in Danish patients with multiple sclerosis, Brain, vol.127, issue.4, pp.844-50, 2004.
DOI : 10.1093/brain/awh104

P. Ragonese, P. Aridon, G. Salemi, D. Amelio, M. Savettieri et al., Mortality in multiple sclerosis: a review, European Journal of Neurology, vol.66, issue.Pt 3, pp.123-130, 2008.
DOI : 10.1111/j.1468-1331.2007.02019.x

A. Scalfari, V. Knappertz, G. Cutter, D. Goodin, R. Ashton et al., Mortality in patients with multiple sclerosis, Neurology, vol.81, issue.2, pp.184-92, 2013.
DOI : 10.1212/WNL.0b013e31829a3388

D. Goodin, A. Reder, G. Ebers, G. Cutter, M. Kremenchutzky et al., Survival in MS, Neurology, vol.78, issue.17, pp.1315-1337, 2012.
DOI : 10.1212/WNL.0b013e3182535cf6

B. Trapp, J. Peterson, R. Ransohoff, R. Rudick, S. Mörk et al., Axonal Transection in the Lesions of Multiple Sclerosis, New England Journal of Medicine, vol.338, issue.5, pp.278-85, 1998.
DOI : 10.1056/NEJM199801293380502

J. Noseworthy, C. Lucchinetti, M. Rodriguez, and B. Weinshenker, Multiple Sclerosis, New England Journal of Medicine, vol.343, issue.13, pp.938-52, 2000.
DOI : 10.1056/NEJM200009283431307

G. Song, S. Choi, J. Ji, and Y. Lee, Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis, Molecular Biology Reports, vol.58, issue.3, pp.2557-64, 2013.
DOI : 10.1007/s11033-012-2341-1

D. Hafler, A. Compston, S. Sawcer, E. Lander, and M. Daly, Risk alleles for multiple sclerosis identified by a genomewide study, N Engl J Med. 30 août, vol.357, issue.9, pp.851-62, 2007.

G. Ebers, Environmental factors and multiple sclerosis, The Lancet Neurology, vol.7, issue.3, pp.268-77, 2008.
DOI : 10.1016/S1474-4422(08)70042-5

G. Dean and J. Kurtzke, On the Risk of Multiple Sclerosis According to Age at Immigration to South Africa, BMJ, vol.3, issue.5777, pp.725-734, 1971.
DOI : 10.1136/bmj.3.5777.725

J. Mcleod, S. Hammond, and J. Kurtzke, Migration and multiple sclerosis in immigrants to Australia from United Kingdom and Ireland: a reassessment. I. Risk of MS by age at immigration, Journal of Neurology, vol.61, issue.Suppl. 24, pp.1140-1149, 2011.
DOI : 10.1007/s00415-010-5898-4

M. Alter, U. Leibowitz, and J. Speer, Risk of Multiple Sclerosis Related to Age at Immigration to Israel, Archives of Neurology, vol.15, issue.3, pp.234-241, 1966.
DOI : 10.1001/archneur.1966.00470150012002

M. Elian, S. Nightingale, and G. Dean, Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies., Journal of Neurology, Neurosurgery & Psychiatry, vol.53, issue.10, pp.906-917, 1990.
DOI : 10.1136/jnnp.53.10.906

G. Delorenze, K. Munger, E. Lennette, N. Orentreich, J. Vogelman et al., Epstein-Barr Virus and Multiple Sclerosis, Archives of Neurology, vol.63, issue.6, pp.839-883, 2006.
DOI : 10.1001/archneur.63.6.noc50328

A. Ascherio and K. Munger, Epstein???Barr Virus Infection and Multiple Sclerosis: A Review, Journal of Neuroimmune Pharmacology, vol.80, issue.6, pp.271-278, 2010.
DOI : 10.1007/s11481-010-9201-3

D. Pohl, Epstein???Barr virus and multiple sclerosis, Journal of the Neurological Sciences, vol.286, issue.1-2, pp.62-66, 2009.
DOI : 10.1016/j.jns.2009.03.028

G. Mameli, V. Astone, G. Arru, S. Marconi, L. Lovato et al., Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6, Journal of General Virology, vol.88, issue.1, pp.264-74, 2007.
DOI : 10.1099/vir.0.81890-0

C. Hawkes, Smoking is a risk factor for multiple sclerosis: a metanalysis, Multiple Sclerosis Journal, vol.98, issue.5, pp.610-615, 2007.
DOI : 10.1177/1352458506073501

J. Salzer, G. Hallmans, M. Nyström, H. Stenlund, G. Wadell et al., Smoking as a risk factor for multiple sclerosis, Multiple Sclerosis Journal, vol.19, issue.8, pp.1022-1029, 2013.
DOI : 10.1093/brain/awq371

A. Hedström, J. Hillert, T. Olsson, and L. Alfredsson, Nicotine might have a protective effect in the etiology of multiple sclerosis, Multiple Sclerosis Journal, vol.67, issue.8, pp.1009-1022, 2013.
DOI : 10.1038/sj.bjp.0707264

M. Hernán, S. Jick, G. Logroscino, M. Olek, A. Ascherio et al., Cigarette smoking and the progression of multiple sclerosis, Brain, vol.128, issue.6, pp.1461-1466, 2005.
DOI : 10.1093/brain/awh471

M. Koch, A. Van-harten, M. Uyttenboogaart, D. Keyser, and J. , Cigarette smoking and progression in multiple sclerosis, Neurology, vol.69, issue.15, pp.1515-1535, 2007.
DOI : 10.1212/01.wnl.0000277658.78381.db

J. Correale, M. Ysrraelit, and M. Gaitán, Immunomodulatory effects of Vitamin D in multiple sclerosis, Brain, vol.132, issue.5, pp.1146-60, 2009.
DOI : 10.1093/brain/awp033

M. Kleinewietfeld, A. Manzel, J. Titze, H. Kvakan, N. Yosef et al., Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells, Nature, vol.197, issue.7446, pp.518-540, 2013.
DOI : 10.1038/nature11868

D. Brassat, Physiopathologie de la scl??rose en plaques, La Presse M??dicale, vol.39, issue.3, pp.341-349, 2010.
DOI : 10.1016/j.lpm.2009.12.001

F. Jadidi-niaragh and A. Mirshafiey, Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis, Scandinavian Journal of Immunology, vol.207, issue.Suppl 5, pp.1-13, 2011.
DOI : 10.1111/j.1365-3083.2011.02536.x

A. Kutzelnigg, C. Lucchinetti, C. Stadelmann, W. Brück, H. Rauschka et al., Cortical demyelination and diffuse white matter injury in multiple sclerosis, Brain, vol.128, issue.11, pp.2705-2717, 2005.
DOI : 10.1093/brain/awh641

J. Frischer, S. Bramow, A. Dal-bianco, C. Lucchinetti, H. Rauschka et al., The relation between inflammation and neurodegeneration in multiple sclerosis brains, Brain, vol.132, issue.5, pp.1175-89, 2009.
DOI : 10.1093/brain/awp070

R. Zivadinov and A. Minagar, Evidence for gray matter pathology in multiple sclerosis: A neuroimaging approach, Journal of the Neurological Sciences, vol.282, issue.1-2, pp.1-4, 2009.
DOI : 10.1016/j.jns.2009.03.014

H. Lassmann, J. Van-horssen, and D. Mahad, Progressive multiple sclerosis: pathology and pathogenesis, Nature Reviews Neurology, vol.17, issue.11, pp.647-56, 2012.
DOI : 10.1038/nrneurol.2012.168

J. Geurts and F. Barkhof, Grey matter pathology in multiple sclerosis, The Lancet Neurology, vol.7, issue.9, pp.841-51, 2008.
DOI : 10.1016/S1474-4422(08)70191-1

N. Chiaravalloti and J. Deluca, Cognitive impairment in multiple sclerosis, The Lancet Neurology, vol.7, issue.12, pp.1139-51, 2008.
DOI : 10.1016/S1474-4422(08)70259-X

J. Kurtzke, Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS), Neurology, vol.33, issue.11, pp.1444-52, 1983.
DOI : 10.1212/WNL.33.11.1444

J. Peyser, K. Edwards, C. Poser, and S. Filskov, Cognitive Function in Patients With Multiple Sclerosis, Archives of Neurology, vol.37, issue.9, pp.577-586, 1980.
DOI : 10.1001/archneur.1980.00500580073013

S. Rao, G. Leo, L. Bernardin, and F. Unverzagt, Cognitive dysfunction in multiple sclerosis.: I. Frequency, patterns, and prediction, Neurology, vol.41, issue.5, pp.685-91, 1991.
DOI : 10.1212/WNL.41.5.685

M. Drew, L. Tippett, N. Starkey, and R. Isler, Executive dysfunction and cognitive impairment in a large community-based sample with Multiple Sclerosis from New Zealand: A descriptive study, Archives of Clinical Neuropsychology, vol.23, issue.1, pp.1-19, 2008.
DOI : 10.1016/j.acn.2007.09.005

T. Olivares, A. Nieto, M. Sánchez, T. Wollmann, M. Hernández et al., Pattern of neuropsychological impairment in the early phase of relapsing-remitting multiple sclerosis, Multiple Sclerosis Journal, vol.43, issue.2, pp.191-198, 2005.
DOI : 10.1002/ana.410130302

U. Nocentini, P. Pasqualetti, S. Bonavita, M. Buccafusca, D. Caro et al., Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis, Multiple Sclerosis Journal, vol.63, issue.1, pp.77-87, 2006.
DOI : 10.1212/WNL.33.11.1444

D. Sonneville, L. Boringa, J. Reuling, I. Lazeron, R. Adèr et al., Information processing characteristics in subtypes of multiple sclerosis, Neuropsychologia, vol.40, issue.11, pp.1751-65, 2002.
DOI : 10.1016/S0028-3932(02)00041-6

C. Archibald and J. Fisk, Information Processing Efficiency in Patients with Multiple Sclerosis, Journal of Clinical and Experimental Neuropsychology (Neuropsychology, Development and Cognition: Section A), vol.22, issue.5, pp.686-701, 2000.
DOI : 10.1076/1380-3395(200010)22:5;1-9;FT686

P. Arnett, C. Higginson, W. Voss, W. Bender, J. Wurst et al., Depression in multiple sclerosis: Relationship to working memory capacity., Neuropsychology, vol.13, issue.4, pp.546-56, 1999.
DOI : 10.1037/0894-4105.13.4.546

P. Arnett, C. Higginson, and J. Randolph, Depression in multiple sclerosis: Relationship to planning ability, Journal of the International Neuropsychological Society, vol.7, issue.6, pp.665-74, 2001.
DOI : 10.1017/S1355617701766027

R. Schiffer and E. Caine, The interaction between depressive affective disorder and neuropsychological test performance in multiple sclerosis patients, J Neuropsychiatry Clin Neurosci, vol.3, issue.1, pp.28-32, 1991.

A. Thornton and N. Raz, Memory impairment in multiple sclerosis: A quantitative review., Neuropsychology, vol.11, issue.3, pp.357-66, 1997.
DOI : 10.1037/0894-4105.11.3.357

K. Zakzanis, Distinct Neurocognitive Profiles in Multiple Sclerosis Subtypes, Archives of Clinical Neuropsychology, vol.15, issue.2, pp.115-151, 2000.
DOI : 10.1093/arclin/15.2.115

J. Deluca, S. Barbieri-berger, and S. Johnson, The nature of memory impairments in multiple sclerosis: Acquisition versus retrieval, Journal of Clinical and Experimental Neuropsychology, vol.44, issue.2, pp.183-192, 1994.
DOI : 10.1080/01688638908400926

M. Jehna, C. Neuper, K. Petrovic, M. Wallner-blazek, R. Schmidt et al., An exploratory study on emotion recognition in patients with a clinically isolated syndrome and multiple sclerosis, Clinical Neurology and Neurosurgery, vol.112, issue.6, pp.482-486, 2010.
DOI : 10.1016/j.clineuro.2010.03.020

M. Kraemer, M. Herold, J. Uekermann, B. Kis, J. Wiltfang et al., Theory of mind and empathy in patients at an early stage of relapsing remitting multiple sclerosis, Clinical Neurology and Neurosurgery, vol.115, issue.7, pp.1016-1038, 2013.
DOI : 10.1016/j.clineuro.2012.10.027

J. Pöttgen, I. Dziobek, S. Reh, C. Heesen, and S. Gold, Impaired social cognition in multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.84, issue.5, pp.523-531, 2013.
DOI : 10.1136/jnnp-2012-304157

L. Vleugels, C. Lafosse, A. Van-nunen, S. Nachtergaele, P. Ketelaer et al., Visuoperceptual impairment in multiple sclerosis patients diagnosed with neuropsychological tasks, Multiple Sclerosis, vol.6, issue.4, pp.241-54, 2000.
DOI : 10.1191/135245800678827879

S. Rao, Neuropsychology of multiple sclerosis, Current Opinion in Neurology, vol.8, issue.3, pp.216-236, 1995.
DOI : 10.1097/00019052-199506000-00010

J. Trauchessec, G. Castelnovo, and P. Labauge, LangSEP: Etude sur les troubles de la dénomination orale chez les patients atteints de sclérose en plaques. Le langage oral: données actuelles et perspectives en orthophonie

G. Moreno, M. , C. García, M. Marasescu, R. et al., Neuropsychological syndromes in multiple sclerosis, Psicothema, vol.25, issue.4, pp.452-60, 2013.

M. Zarei, S. Chandran, A. Compston, and J. Hodges, Cognitive presentation of multiple sclerosis: evidence for a cortical variant, Journal of Neurology, Neurosurgery & Psychiatry, vol.74, issue.7, pp.872-879, 2003.
DOI : 10.1136/jnnp.74.7.872

R. Assouad, C. Louapre, A. Tourbah, C. Papeix, D. Galanaud et al., Clinical and MRI characterization of MS patients with a pure and severe cognitive onset, Clinical Neurology and Neurosurgery, vol.126, pp.55-63, 2014.
DOI : 10.1016/j.clineuro.2014.08.018

URL : https://hal.archives-ouvertes.fr/hal-01251574

R. Benedict, J. Fischer, C. Archibald, P. Arnett, W. Beatty et al., Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach, The Clinical Neuropsychologist (Neuropsychology, Development and Cognition: Section D), vol.16, issue.3, pp.381-97, 2002.
DOI : 10.1076/clin.16.3.381.13859

L. Strober, J. Englert, F. Munschauer, B. Weinstock-guttman, S. Rao et al., Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS, Multiple Sclerosis, vol.15, issue.9, pp.1077-84, 2009.
DOI : 10.1177/1352458509106615

K. Dujardin, P. Sockeel, M. Cabaret, D. Sèze, J. Vermersch et al., La BCcogSEP : une batterie courte d?????valuation des fonctions cognitives destin??es aux patients souffrant de scl??rose en plaques, Revue Neurologique, vol.160, issue.1, pp.51-62, 2004.
DOI : 10.1016/S0035-3787(04)70847-4

B. Parmenter, B. Weinstock-guttman, N. Garg, F. Munschauer, and R. Benedict, Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test, Multiple Sclerosis Journal, vol.11, issue.1, pp.52-59, 2007.
DOI : 10.1080/13803390490496641

A. Ruet, M. Deloire, J. Charré-morin, D. Hamel, and B. Brochet, A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis, Multiple Sclerosis Journal, vol.19, issue.12, pp.1665-72, 2013.
DOI : 10.1177/135245850100700409

M. Younes, J. Hill, J. Quinless, M. Kilduff, B. Peng et al., Internet-based cognitive testing in multiple sclerosis, Multiple Sclerosis Journal, vol.12, issue.8, pp.1011-1020, 2007.
DOI : 10.1076/clin.16.3.381.13859

D. Langdon, M. Amato, J. Boringa, B. Brochet, F. Foley et al., Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), Multiple Sclerosis Journal, vol.97, issue.6, pp.891-899, 2012.
DOI : 10.1016/j.clinthera.2009.08.003

W. Beatty and D. Goodkin, Screening for Cognitive Impairment in Multiple Sclerosis, Archives of Neurology, vol.47, issue.3, pp.297-301, 1990.
DOI : 10.1001/archneur.1990.00530030069018

L. Feuillet, F. Reuter, B. Audoin, I. Malikova, K. Barrau et al., Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis, Multiple Sclerosis Journal, vol.76, issue.1, pp.124-131, 2007.
DOI : 10.1002/ana.1032

URL : https://hal.archives-ouvertes.fr/hal-00169069

C. Potagas, E. Giogkaraki, G. Koutsis, D. Mandellos, E. Tsirempolou et al., Cognitive impairment in different MS subtypes and clinically isolated syndromes, Journal of the Neurological Sciences, vol.267, issue.1-2, pp.100-106, 2008.
DOI : 10.1016/j.jns.2007.10.002

A. Achiron and Y. Barak, Cognitive impairment in probable multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.74, issue.4, pp.443-449, 2003.
DOI : 10.1136/jnnp.74.4.443

V. Zipoli, B. Goretti, B. Hakiki, G. Siracusa, S. Sorbi et al., Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes, Multiple Sclerosis Journal, vol.16, issue.1, pp.62-69, 2010.
DOI : 10.1177/1352458509350311

M. Amato, B. Hakiki, B. Goretti, F. Rossi, M. Stromillo et al., Association of MRI metrics and cognitive impairment in radiologically isolated syndromes, Neurology, vol.78, issue.5, pp.309-323, 2012.
DOI : 10.1212/WNL.0b013e31824528c9

J. Correale, I. Peirano, and L. Romano, Benign multiple sclerosis: a new definition of this entity is needed, Multiple Sclerosis Journal, vol.18, issue.2, pp.210-218, 2012.
DOI : 10.1177/1352458511419702

S. Huijbregts, N. Kalkers, L. De-sonneville, V. De-groot, I. Reuling et al., Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS, Neurology, vol.63, issue.2, pp.335-344, 2004.
DOI : 10.1212/01.WNL.0000129828.03714.90

S. Huijbregts, N. Kalkers, L. De-sonneville, V. De-groot, and C. Polman, Cognitive impairment and decline in different MS subtypes, Journal of the Neurological Sciences, vol.245, issue.1-2, pp.187-94, 2006.
DOI : 10.1016/j.jns.2005.07.018

D. Denney, L. Sworowski, and S. Lynch, Cognitive impairment in three subtypes of multiple sclerosis, Archives of Clinical Neuropsychology, vol.20, issue.8, pp.967-81, 2005.
DOI : 10.1016/j.acn.2005.04.012

A. Ruet, M. Deloire, J. Charré-morin, D. Hamel, and B. Brochet, Cognitive impairment differs between primary progressive and relapsing-remitting MS, Neurology, vol.80, issue.16, pp.1501-1509, 2013.
DOI : 10.1212/WNL.0b013e31828cf82f

S. Lynch, B. Parmenter, and D. Denney, The association between cognitive impairment and physical disability in multiple sclerosis, Multiple Sclerosis Journal, vol.16, issue.4, pp.469-76, 2005.
DOI : 10.1017/S1355617704107030

L. Julian, N. Merluzzi, and D. Mohr, The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosis, Multiple Sclerosis Journal, vol.10, issue.1, pp.81-87, 2007.
DOI : 10.1007/BF02260859

Y. Maor, L. Olmer, and B. Mozes, The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients--the role of depression, Mult Scler. avr, vol.7, issue.2, pp.131-136, 2001.

R. Benedict, F. Munschauer, R. Linn, C. Miller, E. Murphy et al., Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire, Multiple Sclerosis Journal, vol.45, issue.1, pp.95-101, 2003.
DOI : 10.1093/brain/122.5.871

R. Marrie, G. Chelune, D. Miller, and J. Cohen, Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis, Multiple Sclerosis Journal, vol.9, issue.1, pp.69-75, 2005.
DOI : 10.1191/1352458505ms1110oa

I. Fishman, R. Benedict, R. Bakshi, R. Priore, and B. Weinstock-guttman, Construct Validity and Frequency of Euphoria Sclerotica in Multiple Sclerosis, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.16, issue.3, pp.350-356, 2004.
DOI : 10.1176/jnp.16.3.350

L. Krupp and L. Elkins, Fatigue and declines in cognitive functioning in multiple sclerosis, Neurology, vol.55, issue.7, pp.934-943, 2000.
DOI : 10.1212/WNL.55.7.934

L. Fisniku, D. Chard, J. Jackson, V. Anderson, D. Altmann et al., Gray matter atrophy is related to long-term disability in multiple sclerosis, Annals of Neurology, vol.338, issue.pt 11, pp.247-54, 2008.
DOI : 10.1002/ana.21423

D. Li, U. Held, J. Petkau, M. Daumer, F. Barkhof et al., MRI T2 lesion burden in multiple sclerosis: A plateauing relationship with clinical disability, Neurology, vol.66, issue.9, pp.1384-1393, 2006.
DOI : 10.1212/01.wnl.0000210506.00078.5c

A. Ruet, M. Steenwiik, A. Versteeg, M. Daams, P. Pouwels et al., White matter abnormalities and gray matter atrophy measurements in long disease duration multiple sclerosis: prediction of a benign course, ECTRIMS, 2014.

P. Arnett, S. Rao, L. Bernardin, J. Grafman, F. Yetkin et al., Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis, Neurology, vol.44, issue.3, Part 1, pp.420-425, 1994.
DOI : 10.1212/WNL.44.3_Part_1.420

J. Foong, L. Rozewicz, G. Quaghebeur, C. Davie, L. Kartsounis et al., Executive function in multiple sclerosis. The role of frontal lobe pathology, Brain, vol.120, issue.1, pp.15-26, 1997.
DOI : 10.1093/brain/120.1.15

M. Rovaris, G. Comi, and M. Filippi, MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction, Journal of the Neurological Sciences, vol.245, issue.1-2, pp.111-117, 2006.
DOI : 10.1016/j.jns.2005.07.014

R. Zivadinov, J. Sepcic, D. Nasuelli, D. Masi, R. Bragadin et al., A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.70, issue.6, pp.773-80, 2001.
DOI : 10.1136/jnnp.70.6.773

M. Amato, E. Portaccio, B. Goretti, V. Zipoli, M. Battaglini et al., Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis, Archives of Neurology, vol.64, issue.8, pp.1157-61, 2007.
DOI : 10.1001/archneur.64.8.1157

M. Calabrese, F. Agosta, F. Rinaldi, I. Mattisi, P. Grossi et al., Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis, Archives of Neurology, vol.66, issue.9, pp.1144-50, 2009.
DOI : 10.1001/archneurol.2009.174

R. Benedict, J. Bruce, and M. Dwyer, Neocortical Atrophy, Third Ventricular Width, and Cognitive Dysfunction in Multiple Sclerosis, Archives of Neurology, vol.63, issue.9, pp.1301-1307, 2006.
DOI : 10.1001/archneur.63.9.1301

S. Roosendaal, K. Bendfeldt, H. Vrenken, C. Polman, S. Borgwardt et al., Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability, Multiple Sclerosis Journal, vol.17, issue.9, pp.1098-106, 2011.
DOI : 10.1177/1352458511404916

G. Davies, Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.75, issue.7, pp.998-1002, 2004.
DOI : 10.1136/jnnp.2003.021915

R. Henry, M. Shieh, B. Amirbekian, S. Chung, D. Okuda et al., Connecting white matter injury and thalamic atrophy in clinically isolated syndromes, Journal of the Neurological Sciences, vol.282, issue.1-2, pp.61-67, 2009.
DOI : 10.1016/j.jns.2009.02.379

I. Pirko, C. Lucchinetti, S. Sriram, and R. Bakshi, Gray matter involvement in multiple sclerosis, Neurology, vol.68, issue.9, pp.634-676, 2007.
DOI : 10.1212/01.wnl.0000250267.85698.7a

D. Chard and D. Miller, Grey matter pathology in clinically early multiple sclerosis: Evidence from magnetic resonance imaging, Journal of the Neurological Sciences, vol.282, issue.1-2, pp.5-11, 2009.
DOI : 10.1016/j.jns.2009.01.012

S. Messina and P. F. , Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI, Multiple Sclerosis International, vol.125, issue.2, p.609694, 2014.
DOI : 10.1191/135248506ms1301oa

R. Benedict, R. Zivadinov, D. Carone, B. Weinstock-guttman, J. Gaines et al., Regional lobar atrophy predicts memory impairment in multiple sclerosis, AJNR Am J Neuroradiol. août, vol.26, issue.7, pp.1824-1855, 2005.

F. Fink, P. Eling, E. Rischkau, N. Beyer, B. Tomandl et al., The association between California Verbal Learning Test performance and fibre impairment in multiple sclerosis: evidence from diffusion tensor imaging, Multiple Sclerosis Journal, vol.125, issue.6, pp.332-373, 2010.
DOI : 10.1016/S1474-4422(08)70163-7

M. Filippi, M. Rocca, R. Benedict, J. Deluca, J. Geurts et al., The contribution of MRI in assessing cognitive impairment in multiple sclerosis, Neurology, vol.75, issue.23, pp.2121-2129, 2010.
DOI : 10.1212/WNL.0b013e318200d768

M. Sanfilipo, R. Benedict, B. Weinstock-guttman, and R. Bakshi, Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis, Neurology, vol.66, issue.5, pp.685-92, 2006.
DOI : 10.1212/01.wnl.0000201238.93586.d9

A. Papadopoulou, N. Müller-lenke, Y. Naegelin, G. Kalt, K. Bendfeldt et al., Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis, Multiple Sclerosis Journal, vol.67, issue.10, pp.1290-1296, 2013.
DOI : 10.1007/s00115-004-1729-0

S. Roosendaal, J. Geurts, H. Vrenken, H. Hulst, K. Cover et al., Regional DTI differences in multiple sclerosis patients, NeuroImage, vol.44, issue.4, pp.1397-403, 2009.
DOI : 10.1016/j.neuroimage.2008.10.026

R. Dineen, J. Vilisaar, J. Hlinka, C. Bradshaw, P. Morgan et al., Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis, Brain, vol.132, issue.1, pp.239-288, 2009.
DOI : 10.1093/brain/awn275

S. Rao, G. Leo, L. Ellington, T. Nauertz, L. Bernardin et al., Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning, Neurology, vol.41, issue.5, pp.692-698, 1991.
DOI : 10.1212/WNL.41.5.692

M. Amato, G. Ponziani, G. Siracusa, and S. Sorbi, Cognitive Dysfunction in Early-Onset Multiple Sclerosis, Archives of Neurology, vol.58, issue.10, pp.1602-1608, 2001.
DOI : 10.1001/archneur.58.10.1602

A. Ruet, M. Deloire, D. Hamel, J. Ouallet, K. Petry et al., Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study, Journal of Neurology, vol.257, issue.6, pp.776-84, 2013.
DOI : 10.1007/s00415-012-6705-1

N. Téllez, J. Río, M. Tintoré, C. Nos, I. Galán et al., Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?, Multiple Sclerosis Journal, vol.59, issue.2, pp.198-202, 2005.
DOI : 10.1002/ana.410130302

J. Iriarte, M. Subirá, and P. Castro, Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors, Multiple Sclerosis, vol.6, issue.2, pp.124-154, 2000.
DOI : 10.1191/135245800678827572

J. Fisk, A. Pontefract, P. Ritvo, C. Archibald, and T. Murray, ABSTRACT:, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, vol.33, issue.01, pp.9-14, 1994.
DOI : 10.1016/0304-3959(85)90078-8

L. Krupp, N. Larocca, J. Muir-nash, and A. Steinberg, The Fatigue Severity Scale, Archives of Neurology, vol.46, issue.10, pp.1121-1124, 1989.
DOI : 10.1001/archneur.1989.00520460115022

M. Debouverie, S. Pittion-vouyovitch, S. Louis, and F. Guillemin, Validity of a French version of the fatigue impact scale in multiple sclerosis, Multiple Sclerosis Journal, vol.8, issue.1, pp.1026-1058, 2007.
DOI : 10.1191/1352458505ms1148oa

D. Kroencke, S. Lynch, and D. Denney, Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern, Multiple Sclerosis Journal, vol.45, issue.1, pp.131-137, 2000.
DOI : 10.1002/ana.410130302

S. Pittion-vouyovitch, M. Debouverie, F. Guillemin, N. Vandenberghe, R. Anxionnat et al., Fatigue in multiple sclerosis is related to disability, depression and quality of life, Journal of the Neurological Sciences, vol.243, issue.1-2, pp.39-45, 2006.
DOI : 10.1016/j.jns.2005.11.025

D. Trojan, D. Arnold, J. Collet, S. Shapiro, A. Bar-or et al., Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors, Multiple Sclerosis Journal, vol.12, issue.6, pp.985-95, 2007.
DOI : 10.1212/WNL.33.11.1444

R. Benedict, E. Wahlig, R. Bakshi, I. Fishman, F. Munschauer et al., Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change, Journal of the Neurological Sciences, vol.231, issue.1-2, pp.29-34, 2005.
DOI : 10.1016/j.jns.2004.12.009

A. Feinstein, An examination of suicidal intent in patients with multiple sclerosis, Neurology, vol.59, issue.5, pp.674-682, 2002.
DOI : 10.1212/WNL.59.5.674

R. Bakshi, Z. Shaikh, R. Miletich, D. Czarnecki, J. Dmochowski et al., Fatigue in multiple sclerosis and its relationship to depression and neurologic disability, Multiple Sclerosis, vol.6, issue.3, pp.181-186, 2000.
DOI : 10.1191/135245800701566052

R. Siegert and D. Abernethy, Depression in multiple sclerosis: a review, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.4, pp.469-75, 2005.
DOI : 10.1136/jnnp.2004.054635

K. Honarmand and A. Feinstein, Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients, Multiple Sclerosis Journal, vol.15, issue.12, pp.1518-1542, 2009.
DOI : 10.1002/ana.1032

S. Minden, A. Feinstein, R. Kalb, D. Miller, D. Mohr et al., Evidence-based guideline: Assessment and management of psychiatric disorders in individuals with MS: Report of the Guideline Development Subcommittee of the American Academy of Neurology, Neurology, vol.82, issue.2, pp.174-81, 2014.
DOI : 10.1212/WNL.0000000000000013

R. Benedict, I. Fishman, M. Mcclellan, R. Bakshi, and B. Weinstock-guttman, Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis, Multiple Sclerosis Journal, vol.16, issue.2, pp.393-399, 2003.
DOI : 10.1002/ana.1032

P. Rabins, B. Brooks, O. Donnell, P. Pearlson, G. Moberg et al., STRUCTURAL BRAIN CORRELATES OF EMOTIONAL DISORDER IN MULTIPLE SCLEROSIS, Brain, vol.109, issue.4, pp.585-97, 1986.
DOI : 10.1093/brain/109.4.585

R. Bakshi, D. Czarnecki, Z. Shaikh, R. Priore, V. Janardhan et al., Brain MRI lesions and atrophy are related to depression in multiple sclerosis, NeuroReport, vol.11, issue.6, pp.1153-1161, 2000.
DOI : 10.1097/00001756-200004270-00003

L. Passamonti, A. Cerasa, M. Liguori, M. Gioia, P. Valentino et al., Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis, Brain, vol.132, issue.12, pp.3380-91, 2009.
DOI : 10.1093/brain/awp095

A. Feinstein, S. Magalhaes, J. Richard, B. Audet, and C. Moore, The link between multiple sclerosis and depression, Nature Reviews Neurology, vol.4, issue.9, pp.507-524, 2014.
DOI : 10.1097/YCT.0b013e31806548c6

K. Cetin, K. Johnson, D. Ehde, C. Kuehn, D. Amtmann et al., Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample, Multiple Sclerosis Journal, vol.60, issue.7, pp.1046-53, 2007.
DOI : 10.1212/WNL.45.7.1277

A. Feinstein, Multiple sclerosis and depression, Multiple Sclerosis Journal, vol.16, issue.11, pp.1276-81, 2011.
DOI : 10.1191/1352458505ms1162oa

C. Anterion, C. Ribas, S. Honore-masson, G. Berne, J. Ruel et al., Le questionnaire de plainte cognitive (QPC): Un outil de recherche de plainte suspecte d'évoquer une maladie d'Alzheimer? L' Année gérontologique, pp.56-65, 2003.

A. Zigmond and R. Snaith, The Hospital Anxiety and Depression Scale, Acta Psychiatrica Scandinavica, vol.141, issue.6, pp.361-70, 1983.
DOI : 10.1111/j.1600-0447.1983.tb09716.x

M. Debouverie, S. Pittion, F. Guillemin, and H. Vespignani, Fatigue scales used in multiple sclerosis], Rev Neurol nov, vol.158, issue.11, pp.1139-1182, 2002.

T. Tombaugh, A comprehensive review of the Paced Auditory Serial Addition Test (PASAT), Archives of Clinical Neuropsychology, vol.21, issue.1, pp.53-76, 2006.
DOI : 10.1016/j.acn.2005.07.006

N. Figved, K. Myhr, J. Larsen, D. Aarsland, and . &amp, Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms, Journal of Neurology, Neurosurgery & Psychiatry, vol.78, issue.10, pp.1097-102, 2007.
DOI : 10.1136/jnnp.2006.104216

H. Brissart, M. Sauvée, C. Latarche, C. Dillier, and M. Debouverie, Integration of Cognitive Impairment in the Expanded Disability Status Scale of 215 Patients with Multiple Sclerosis, European Neurology, vol.64, issue.6, pp.345-50, 2010.
DOI : 10.1159/000322140

J. Fischer, R. Rudick, G. Cutter, and S. Reingold, The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment, Multiple Sclerosis Journal, vol.7, issue.4, pp.244-50, 1999.
DOI : 10.1002/ana.410390304

C. Polman and R. Rudick, The Multiple Sclerosis Functional Composite: A clinically meaningful measure of disability, Neurology, vol.74, issue.Issue 17, Supplement 3, pp.8-15, 2010.
DOI : 10.1212/WNL.0b013e3181dbb571

G. Defer, F. Daniel, N. Derache, G. Defer, F. Daniel et al., Therapeutic management of cognitive disorders in multiple sclerosis], [Therapeutic management of cognitive disorders in multiple sclerosis]. Revue Neurologique, Revue Neurologique, pp.163-169, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00383224

M. Amato, D. Langdon, X. Montalban, R. Benedict, J. Deluca et al., Treatment of cognitive impairment in multiple sclerosis: position paper, Journal of Neurology, vol.18, issue.6, pp.1452-68, 2013.
DOI : 10.1007/s00415-012-6678-0

M. Geisler, M. Sliwinski, P. Coyle, D. Masur, C. Doscher et al., The Effects of Amantadine and Pemoline on Cognitive Functioning in Multiple Sclerosis, Archives of Neurology, vol.53, issue.2, pp.185-193, 1996.
DOI : 10.1001/archneur.1996.00550020101021

J. Sumowski, N. Chiaravalloti, D. Erlanger, T. Kaushik, R. Benedict et al., L-amphetamine improves memory in MS patients with objective memory impairment, Multiple Sclerosis Journal, vol.17, issue.9, pp.1141-1146, 2011.
DOI : 10.1177/1352458511404585

P. Rossini, P. Pasqualetti, C. Pozzilli, M. Grasso, E. Millefiorini et al., Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine, Multiple Sclerosis, vol.7, issue.6, pp.354-362, 2001.
DOI : 10.1191/135245801701567050

L. Krupp, C. Christodoulou, P. Melville, W. Scherl, L. Pai et al., Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis, Neurology, vol.76, issue.17, pp.1500-1507, 2011.
DOI : 10.1212/WNL.0b013e318218107a

V. Shaygannejad, M. Janghorbani, F. Ashtari, H. Zanjani, and N. Zakizade, Conclusion:, The Canadian Journal of Neurological Sciences, vol.2, issue.04, pp.476-81, 2008.
DOI : 10.1159/000047940

D. He, Y. Zhang, S. Dong, D. Wang, X. Gao et al., Pharmacological treatment for memory disorder in multiple sclerosis, Cochrane Database Syst Rev, vol.30, issue.10, p.8876, 2013.
DOI : 10.1002/14651858.CD008876.pub3

C. Bensa, E. Bodiguel, D. Brassat, D. Laplaud, L. Magy et al., Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis, Revue Neurologique, vol.168, issue.11, pp.785-94, 2012.
DOI : 10.1016/j.neurol.2012.02.009

F. Patti, Treatment of cognitive impairment in patients with multiple sclerosis, Expert Opinion on Investigational Drugs, vol.33, issue.5, pp.1679-99, 2012.
DOI : 10.1177/1352458507078393

F. Patti, M. Amato, S. Bastianello, L. Caniatti, D. Monte et al., Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing--remitting multiple sclerosis, Multiple Sclerosis Journal, vol.16, issue.1, pp.68-77, 2010.
DOI : 10.1177/1352458509350309

Y. Barak and A. Achiron, Effect of Interferon-beta-1b on Cognitive Functions in Multiple Sclerosis, European Neurology, vol.47, issue.1, pp.11-15, 2002.
DOI : 10.1159/000047940

A. Weinstein, S. Schwid, R. Schiffer, M. Mcdermott, D. Giang et al., Neuropsychologic Status in Multiple Sclerosis After Treatment With Glatiramer, Archives of Neurology, vol.56, issue.3, pp.319-343, 1999.
DOI : 10.1001/archneur.56.3.319

F. Mattioli, C. Stampatori, and R. Capra, The effect of natalizumab on cognitive function in patients with relapsing-remitting multiple sclerosis: preliminary results of a 1-year follow-up study, Neurological Sciences, vol.255, issue.Suppl, pp.83-91, 2011.
DOI : 10.1007/s10072-010-0412-4

J. Cohen, F. Barkhof, G. Comi, H. Hartung, B. Khatri et al., Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis, New England Journal of Medicine, vol.362, issue.5, pp.402-417, 2010.
DOI : 10.1056/NEJMoa0907839

URL : https://hal.archives-ouvertes.fr/hal-00617750

D. Miller, D. Soon, K. Fernando, D. Macmanus, G. Barker et al., MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS, Neurology, vol.68, issue.17, pp.1390-401, 2007.
DOI : 10.1212/01.wnl.0000260064.77700.fd

M. Sormani, D. Arnold, D. Stefano, and N. , Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis, Annals of Neurology, vol.70, issue.1, pp.43-52, 2014.
DOI : 10.1002/ana.24018

E. Rosti-otajärvi and P. Hämäläinen, Neuropsychological rehabilitation for multiple sclerosis, Cochrane Database Syst Rev, vol.2, p.9131, 2014.

R. Benedict and R. Zivadinov, Risk factors for and management of cognitive dysfunction in multiple sclerosis, Nature Reviews Neurology, vol.44, issue.6, pp.332-374, 2011.
DOI : 10.1038/nrneurol.2011.61

M. Bonnet, M. Deloire, E. Salort, V. Dousset, K. Petry et al., Evidence of cognitive compensation associated with educational level in early relapsing???remitting multiple sclerosis, Journal of the Neurological Sciences, vol.251, issue.1-2, pp.23-31, 2006.
DOI : 10.1016/j.jns.2006.08.002

I. Penner, K. Opwis, and L. Kappos, Relation between functional brain imaging, cognitive impairment and cognitive rehabilitation in patients with multiple sclerosis, Journal of Neurology, vol.13, issue.S2, pp.53-60, 2007.
DOI : 10.1007/s00415-007-2013-6